Prognoz Oslozhneniy Luchevoy Terapii Raka Prostaty
| AUTHOR | Al'bitskiy Igor' |
| PUBLISHER | LAP Lambert Academic Publishing (02/22/2012) |
| PRODUCT TYPE | Paperback (Paperback) |
Description
Radikal'naya programma distantsionnoy luchevoy terapii s ispol'zovaniem vysokoenergeticheskogo puchka protonov ispol'zuetsya v Rossiyskom Nauchnom Tsentre Rentgenoradiologii s 2000g. Iz provedennogo analiza vidno, chto i osnovnaya (protonno-fotonnaya luchevaya terapiya) i kontrol'naya gruppy standartny po kolichestvu bol'nykh - 62 (42%) i 89 (58%) sootvetstvenno; rasprostranennosti opukholi; prognosticheskim faktoram; nalichiyu soputstvuyushchikh zabolevaniy so storony pryamoy kishki i nizhnikh mochevykh putey; urovnyu summarnykh ochagovykh doz (44-46Gr na ves' ob"em malogo taza, 68-72Gr lokal'no na prostatu), da i samo issledovanie bylo randomizirovano v svyazi s ob"ektivnym parametrom - tsiklom raboty sinkhrotsiklotrona v meditsinskikh tselyakh (3-4 raza v techenii goda). V nashey rabote naglyadno pokazano otsutstvie znachimykh dostovernykh otlichiy v bezretsidivnoy vyzhivaemosti bolee 2 let v obeikh gruppakh. Takim obrazom, na pervyy plan v realizatsii radikal'noy distantsionnoy luchevoy terapii raka predst
Show More
Product Format
Product Details
ISBN-13:
9783847347378
ISBN-10:
3847347373
Binding:
Paperback or Softback (Trade Paperback (Us))
Content Language:
Russian
More Product Details
Page Count:
108
Carton Quantity:
72
Product Dimensions:
6.00 x 0.26 x 9.00 inches
Weight:
0.37 pound(s)
Country of Origin:
US
Subject Information
BISAC Categories
Medical | Clinical Medicine
Descriptions, Reviews, Etc.
publisher marketing
Radikal'naya programma distantsionnoy luchevoy terapii s ispol'zovaniem vysokoenergeticheskogo puchka protonov ispol'zuetsya v Rossiyskom Nauchnom Tsentre Rentgenoradiologii s 2000g. Iz provedennogo analiza vidno, chto i osnovnaya (protonno-fotonnaya luchevaya terapiya) i kontrol'naya gruppy standartny po kolichestvu bol'nykh - 62 (42%) i 89 (58%) sootvetstvenno; rasprostranennosti opukholi; prognosticheskim faktoram; nalichiyu soputstvuyushchikh zabolevaniy so storony pryamoy kishki i nizhnikh mochevykh putey; urovnyu summarnykh ochagovykh doz (44-46Gr na ves' ob"em malogo taza, 68-72Gr lokal'no na prostatu), da i samo issledovanie bylo randomizirovano v svyazi s ob"ektivnym parametrom - tsiklom raboty sinkhrotsiklotrona v meditsinskikh tselyakh (3-4 raza v techenii goda). V nashey rabote naglyadno pokazano otsutstvie znachimykh dostovernykh otlichiy v bezretsidivnoy vyzhivaemosti bolee 2 let v obeikh gruppakh. Takim obrazom, na pervyy plan v realizatsii radikal'noy distantsionnoy luchevoy terapii raka predst
Show More
Your Price
$62.84
